Showing results (591-600 of 640) with videos related to

Sort By:
Pageof 64
The Journal of Urology|August 1, 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancerM F Sarosdy, R W deVere White, M S Soloway, et al.
Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.
Urology|February 7, 2007
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancerCora N Sternberg, S Machele Donat, Joaquim Bellmunt, et al.
Cancer|July 13, 2002
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat testsVinata B Lokeshwar, Grethchen L Schroeder, Marie G Selzer, et al.
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
European Urology|June 16, 2012
Active surveillance for prostate cancer: a systematic review of the literatureMarc A Dall'Era, Peter C Albertsen, Christopher Bangma, et al.
International Urology and Nephrology|June 9, 2012
Impact of body mass index and tumor location on the incidence of benign histology at the time of nephron-sparing surgeryBruce R Kava, Ahmed Eldefrawy, Rajinikanth Ayyathurai, et al.
Cancer|May 15, 1987
Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of lifeC A Presant, M S Soloway, S S Klioze, et al.
The Journal of Urology|December 3, 2013
Differential expression of SDF-1 isoforms in bladder cancerMiguel Gosalbez, Marie C Hupe, Soum D Lokeshwar, et al.
Cancer|November 15, 1996
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.
Pageof 64